REVIEW ARTICLE
Year : 2022 | Volume
: 6 | Issue : 5 | Page : 7--10
Point-of-care thromboelastography, rotational thromboelastometry during extracorporeal membrane oxygenation
Abdullah M Abudayah
Department of Intensive Care Service, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
Correspondence Address:
Abdullah M Abudayah
Department of Intensive Care Service, Prince Sultan Military Medical City, Riyadh
Saudi Arabia
Extracorporeal membrane oxygenation (ECMO) has been used increasingly for both respiratory and cardiac failure in adult patients. The patients requiring ECMO are at increased risk of developing significant coagulopathy. The exposure of a patient's blood to the artificial surface of the ECMO circuit results in the activation of the coagulation-fibrinolysis system and an inflammatory response. During ECMO, anticoagulation is required to prevent thrombotic complications, and unfractionated heparin (UFH) remains the predominant anticoagulation agent used to minimize the potentially life-threatening complications related to bleeding events or thromboembolic complications. Most centers adjust UFH by activated clotting time (ACT) of 140–180 sec or partial thromboplastin time (PTT) of 40–80 s. In this article, we will review thromboelastometry use during ECMO in ICU.
How to cite this article:
Abudayah AM. Point-of-care thromboelastography, rotational thromboelastometry during extracorporeal membrane oxygenation.Saudi Crit Care J 2022;6:7-10
|
How to cite this URL:
Abudayah AM. Point-of-care thromboelastography, rotational thromboelastometry during extracorporeal membrane oxygenation. Saudi Crit Care J [serial online] 2022 [cited 2023 Mar 29 ];6:7-10
Available from: https://www.sccj-sa.org/article.asp?issn=2543-1854;year=2022;volume=6;issue=5;spage=7;epage=10;aulast=Abudayah;type=0 |
|
